Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

153 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Glucose dependent insulinotropic polypeptide (GIP) infused intravenously is insulinotropic in the fasting state in type 2 (non-insulin dependent) diabetes mellitus.
Jones IR, Owens DR, Luzio S, Hayes TM. Jones IR, et al. Horm Metab Res. 1989 Jan;21(1):23-6. doi: 10.1055/s-2007-1009141. Horm Metab Res. 1989. PMID: 2647605 Clinical Trial.
The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus.
Jones IR, Owens DR, Luzio S, Williams S, Hayes TM. Jones IR, et al. Diabetologia. 1989 Sep;32(9):668-77. doi: 10.1007/BF00274255. Diabetologia. 1989. PMID: 2676668 Clinical Trial.
Impaired activation of skeletal muscle glycogen synthase in non-insulin-dependent diabetes mellitus is unrelated to the degree of obesity.
Johnson AB, Argyraki M, Thow JC, Jones IR, Broughton D, Miller M, Taylor R. Johnson AB, et al. Metabolism. 1991 Mar;40(3):252-60. doi: 10.1016/0026-0495(91)90106-7. Metabolism. 1991. PMID: 1900343
Effect of bezafibrate on metabolic profiles in non-insulin-dependent diabetes mellitus.
Alberti KG, Jones IR, Laker MF, Swai AB, Taylor R. Alberti KG, et al. J Cardiovasc Pharmacol. 1990;16 Suppl 9:S21-4; discussion S24-5. J Cardiovasc Pharmacol. 1990. PMID: 1710741 Clinical Trial.
Soluble and Lente human insulin mixtures in normal man.
Owens DR, Vora JP, Jones IR, Birtwell J, Atiea J, Luzio S, Williams S. Owens DR, et al. Diabetes Res. 1988 Jan;7(1):35-40. Diabetes Res. 1988. PMID: 3042252
The effect of sulphonylurea therapy on skeletal muscle glycogen synthase activity and insulin secretion in newly presenting type 2 (non-insulin-dependent) diabetic patients.
Johnson AB, Argyraki M, Thow JC, Jones IR, Broughton D, Miller M, Taylor R. Johnson AB, et al. Diabet Med. 1991 Apr;8(3):243-53. doi: 10.1111/j.1464-5491.1991.tb01580.x. Diabet Med. 1991. PMID: 1828740 Clinical Trial.
Glycosylated serum albumin: an intermediate index of diabetic control.
Jones IR, Owens DR, Williams S, Ryder RE, Birtwell AJ, Jones MK, Gicheru K, Hayes TM. Jones IR, et al. Diabetes Care. 1983 Sep-Oct;6(5):501-3. doi: 10.2337/diacare.6.5.501. Diabetes Care. 1983. PMID: 6336346
The effects of glucose-dependent insulinotropic polypeptide infused at physiological concentrations in normal subjects and type 2 (non-insulin-dependent) diabetic patients on glucose tolerance and B-cell secretion.
Jones IR, Owens DR, Moody AJ, Luzio SD, Morris T, Hayes TM. Jones IR, et al. Diabetologia. 1987 Sep;30(9):707-12. doi: 10.1007/BF00296993. Diabetologia. 1987. PMID: 3322911
Retinopathy in newly presenting non-insulin-dependent (type 2) diabetic patients.
Owens DR, Vølund A, Jones D, Shannon AG, Jones IR, Birtwell AJ, Luzio S, Williams S, Dolben J, Creagh FN, et al. Owens DR, et al. Diabetes Res. 1988 Oct;9(2):59-65. Diabetes Res. 1988. PMID: 3073031
153 results
Jump to page
Feedback